0001437749-24-018133.txt : 20240523
0001437749-24-018133.hdr.sgml : 20240523
20240523154257
ACCESSION NUMBER: 0001437749-24-018133
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240521
FILED AS OF DATE: 20240523
DATE AS OF CHANGE: 20240523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tarnok Michael P.
CENTRAL INDEX KEY: 0001413525
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32513
FILM NUMBER: 24977875
BUSINESS ADDRESS:
BUSINESS PHONE: (212) 531-5965
MAIL ADDRESS:
STREET 1: KERYX BIOPHARMACEUTICALS, INC.
STREET 2: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYADIC INTERNATIONAL INC
CENTRAL INDEX KEY: 0001213809
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 450486747
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1044 NORTH U.S. HIGHWAY ONE
STREET 2: SUITE 201
CITY: JUPITER
STATE: FL
ZIP: 33477
BUSINESS PHONE: 561-743-8333
MAIL ADDRESS:
STREET 1: 1044 NORTH U.S. HIGHWAY ONE
STREET 2: SUITE 201
CITY: JUPITER
STATE: FL
ZIP: 33477
FORMER COMPANY:
FORMER CONFORMED NAME: CCP WORLDWIDE INC
DATE OF NAME CHANGE: 20030110
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-05-21
0001213809
DYADIC INTERNATIONAL INC
DYAI
0001413525
Tarnok Michael P.
C/O DYADIC INTERNATIONAL, INC.
1044 NORTH U.S. HIGHWAY ONE, SUITE 201
JUPITER
FL
33477-5094
1
0
Common Stock
2024-05-21
4
M
0
7500
1.36
A
223603
D
Common Stock
2024-05-21
4
M
0
5625
1.36
A
229228
D
Common Stock
2024-05-21
4
M
0
16875
1.36
A
246103
D
Common Stock
2024-05-21
4
F
0
24431
1.67
D
221672
D
Stock Option
1.36
2024-05-21
4
M
0
7500
0
D
2014-06-12
2024-06-11
Common Stock
7500
0
D
Stock Option
1.36
2024-05-21
4
M
0
5625
0
D
2015-06-12
2024-06-11
Common Stock
5625
0
D
Stock Option
1.36
2024-05-21
4
M
0
16875
0
D
2015-12-31
2024-06-11
Common Stock
16875
0
D
The reporting person exercised a total of 30,000 stock options and paid the exercise price through the withholding by the Issuer of 24,431 shares of common stock underlying the stock options (equal to the value of the exercise price), based on a market price of $1.67, which was the closing price of the Issuer's common stock on May 21, 2024.
/s/ Ping Rawson, attorney-in-fact
2024-05-23